Morinaga&Co (2201) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
15 Oct, 2026Executive summary
H1 FY2025 net sales rose 8.4% YoY to ¥118,845 million; operating income fell 2.2% to ¥13,855 million, while profit attributable to owners of parent rose 3.6% to ¥10,631 million.
Strong domestic Confectionery & Foodstuffs and Frozen Desserts sales supported growth; raw-material inflation and business-strengthening investments weighed on operating income.
Financial highlights
Gross profit increased 5.5% to ¥48,673 million; gross margin was 41.0%, down 1.1pt. SG&A rose 8.9% to ¥34,817 million, including advertising expense up 13.4% to ¥5,450 million.
Ordinary income decreased 2.1% to ¥14,099 million; extraordinary income rose to ¥1,141 million, including ¥895 million from investment-security sales, contributing to higher parent-attributable profit.
H1 sales were 108.4% of initial forecast; operating income reached 97.8% and profit attributable to owners was 103.6%.
Operating cash flow was ¥10,796 million versus ¥17,868 million; investing cash outflow was ¥7,285 million and financing cash outflow was ¥7,749 million.
Outlook and guidance
FY2025 forecast: net sales ¥227,000 million, operating income ¥21,300 million, ordinary income ¥21,700 million and parent-attributable profit ¥16,700 million; year-end dividend forecast remains ¥60 per share.
Versus the May forecast, net sales rose ¥5.0bn and operating income ¥0.8bn; H1 outperformance, domestic growth and pricing benefits partly offset expected H2 raw-material cost pressure.
H2 forecast: sales ¥108,154 million, up 4.2%; operating income ¥7,444 million, up 21.9% YoY, with flexible price revisions and sales growth expected to counter cost inflation.
Forecast overseas subsidiaries use ¥147 per U.S. dollar; a ¥1 yen depreciation is estimated to reduce annual profit by slightly less than ¥0.1bn.
Latest events from Morinaga&Co
- Q1 earnings rose on U.S. growth and price revisions; FY2024 guidance was unchanged.2201
Q1 2024 - Record first-half sales lifted guidance, while second-half investment is expected to weigh on profit.2201
Q2 2024 - Record 9M sales and higher margins lifted full-year forecasts and the dividend.2201
Q3 2024 - Record FY2023 sales and profit growth, with FY2024 growth forecast amid cost headwinds.2201
Q4 2024 - Q1 sales rose 11.4%; a US$136 million U.S. factory will expand HI-CHEW capacity.2201
Q1 2025 - 9M sales grew 7.8%, but raw-material inflation pressured earnings; FY2025 forecasts held.2201
Q3 2025 - FY2025 sales hit a record, while cacao inflation and cash outflows tempered gains.2201
Q4 2025 - H1 operating income fell 3.7%, but FY2026 operating-income guidance rose to ¥22.3bn.2201
Q2 2026 - Core sweets growth and MyMo expansion offset by near-term acquisition costs.2201
Q4 2026